news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

Shanghai, July 27, 2024 - The countdown to the opening of the 7th China International Import Expo (hereinafter referred to as "CIIE") is 100 days away. Bayer, a world-leading life science company, will bring its three major business units of prescription drugs (and imaging diagnosis), health consumer products, and crop science to the annual "Golden Autumn Appointment" for the seventh consecutive year, depicting a healthy and beautiful future with its innovative strength in the two major fields of medical health and agricultural technology.

The government work report released in early 2024 listed "accelerating the cultivation and development of new quality productivity" as the primary goal, stimulating new momentum for the sustainable development of healthcare and agriculture. As a window for China to showcase its new development pattern and a platform for promoting high-level opening up, the 7th CIIE will also become an important stage for showcasing new quality productivity. Bayer will fulfill its firm commitment to the Chinese market, bringing together new technologies and new concepts from around the world to help accelerate the entry of the world's latest innovations into the Chinese market.

Looking back at the past six CIIEs, Bayer has exhibited more than 100 innovative products, presented more than 30 "first exhibitions" and incubated 8 "CIIE babies". These outstanding achievements have witnessed the powerful spillover effect of the CIIE and have continuously deepened the innovation bond shared by Bayer and China. Taking advantage of the opportunity of further opening up and win-win cooperation at the seventh CIIE, Bayer will continue to play its leading role in innovation and work with partners from various industries to empower the public to have a better new life.

This year, Bayer will take its corporate mission of "sharing health, eliminating hunger" as the theme of the CIIE, continuing the "double exhibition" strategy, and the total booth area will continue to expand by 14% from 2023, reaching a record high of 800 square meters. Bayer's Prescription Drug Division will not only showcase innovative products and indications in the fields of cardiovascular, oncology and women's health, but will also share Bayer's latest practices in open innovation and cooperation; Bayer's Health Consumer Products Division will continue to bring an overwhelming array of new products for daily health management, and will join hands with many ecosystem partners to open a new chapter of cooperation; Bayer's Crop Science Division will take "Regenerative Agriculture, Endless Life" as the theme, presenting an innovative, efficient and sustainable "China Solution" for the transformation of global regenerative agriculture, and will also appear in the seed industry area of ​​the food and agricultural products exhibition area for the third time as a "full attendance student", showcasing the world's leading seed industry innovation and local research and development results, and help China's food security.

Diligence brings success in autumn. Bayer will welcome the seventh CIIE in 100 days with full preparation and high spirits, and looks forward to sharing the latest breakthroughs in the fields of medical health and agricultural science and technology with all walks of life, exploring the infinite possibilities of "new" cooperation with partners, sharing China's opportunities, and jointly creating a healthier and better future.